115 related articles for article (PubMed ID: 21919962)
1. Hyperbilirubinemia after hematopoietic stem cell transplantation: comparison of clinical and pathologic findings in 41 autopsied cases.
Kagoya Y; Takahashi T; Nannya Y; Shinozaki A; Ota S; Fukayama M; Kurokawa M
Clin Transplant; 2011; 25(5):E552-7. PubMed ID: 21919962
[TBL] [Abstract][Full Text] [Related]
2. [Liver biopsy in the management of liver dysfunction after allogeneic hematopoietic stem-cell transplantation].
Chen H; Huang XJ; Liu KY; Xu LP; Wang H; Liu DH; Lu J; Lu DP
Zhonghua Yi Xue Za Zhi; 2005 Nov; 85(43):3062-6. PubMed ID: 16324408
[TBL] [Abstract][Full Text] [Related]
3. Liver graft-versus-host disease after donor lymphocyte infusion for relapses of hematologic malignancies post allogeneic hematopoietic stem cell transplantation.
Ma SY; Au WY; Lie AK; Ng IO; Leung AY; Tse EW; Liang RH; Lau GK; Kwong YL
Bone Marrow Transplant; 2004 Jul; 34(1):57-61. PubMed ID: 15156162
[TBL] [Abstract][Full Text] [Related]
4. [Analysis of acute liver "graft-versus-host disease" following allogeneic myeloablative stem cell transplant].
Doki N; Saito Y; Hatsumi N; Irisawa H; Sakura T; Miyawaki S
Rinsho Ketsueki; 2004 Jan; 45(1):57-60. PubMed ID: 14999935
[TBL] [Abstract][Full Text] [Related]
5. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
Petersen SL
Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
[TBL] [Abstract][Full Text] [Related]
6. Histologic features of the liver biopsy predict the clinical outcome for patients with graft-versus-host disease of the liver.
Duarte RF; Delgado J; Shaw BE; Wrench DJ; Ethell M; Patch D; Dhillon AP; Mackinnon S; Potter MN; Quaglia AF
Biol Blood Marrow Transplant; 2005 Oct; 11(10):805-13. PubMed ID: 16182181
[TBL] [Abstract][Full Text] [Related]
7. Role of liver biopsy in the management of liver dysfunction after hematopoietic stem-cell transplantation in a hepatitis B virus-prevalent patient population.
Ma SY; Au WY; Ng IO; Lie AK; Leung AY; Liang RH; Lau GK; Kwong YL
Transplantation; 2003 Jul; 76(1):169-76. PubMed ID: 12865805
[TBL] [Abstract][Full Text] [Related]
8. [Influence of graft-versus-host disease on long-term survival of 26 patients with hematologic malignancies after transplantation].
Lin Q; Dong M; Wang QM; Wen JY; Wu XY
Ai Zheng; 2006 Oct; 25(10):1261-5. PubMed ID: 17059772
[TBL] [Abstract][Full Text] [Related]
9. Histological evaluation of acute mucocutaneous graft-versus-host disease in nonmyeloablative hematologic stem cell transplants with an observation predicting an increased risk of progression to chronic graft-versus-host disease.
Bridge AT; Nelson RP; Schwartz JE; Mirowski GW; Billings SD
Am J Dermatopathol; 2007 Feb; 29(1):1-6. PubMed ID: 17284954
[TBL] [Abstract][Full Text] [Related]
10. Hyperbilirubinemia in the early phase after allogeneic HSCT: prognostic significance of the alkaline phosphatase/total bilirubin ratio.
Ashizawa M; Oshima K; Wada H; Ishihara Y; Kawamura K; Sakamoto K; Sato M; Terasako K; Machishima T; Kimura S; Kikuchi M; Nakasone H; Okuda S; Kako S; Kanda J; Yamazaki R; Tanihara A; Nishida J; Kanda Y
Bone Marrow Transplant; 2013 Jan; 48(1):94-8. PubMed ID: 22750996
[TBL] [Abstract][Full Text] [Related]
11. Hepatitic graft-versus-host disease after hematopoietic stem cell transplantation: clinicopathologic features and prognostic implication.
Ma SY; Au WY; Ng IO; Lie AK; Leung AY; Liang R; Lau GK; Kwong YL
Transplantation; 2004 Apr; 77(8):1252-9. PubMed ID: 15114094
[TBL] [Abstract][Full Text] [Related]
12. Significance of colonoscopy in patients with intestinal graft-versus-host disease after hematopoietic stem cell transplantation.
Oomori S; Takagi S; Kikuchi T; Utsunomiya K; Yokoyama H; Negoro K; Tohmiya Y; Aihara H; Yamada M; Takahashi S; Kameoka J; Kinouchi Y; Shimosegawa T
Endoscopy; 2005 Apr; 37(4):346-50. PubMed ID: 15824945
[TBL] [Abstract][Full Text] [Related]
13. Characterization of acute graft-versus-host disease following reduced-intensity stem-cell transplantation from an HLA-identical related donor.
Murashige N; Kami M; Mori S; Katayama Y; Kobayashi K; Onishi Y; Hori A; Kishi Y; Hamaki T; Tajima K; Kanda Y; Tanosaki R; Takaue Y
Am J Hematol; 2008 Aug; 83(8):630-4. PubMed ID: 18454459
[TBL] [Abstract][Full Text] [Related]
14. Severe acute gastrointestinal graft-vs-host disease: an emerging surgical dilemma in contemporary cancer care.
Irani JL; Cutler CS; Whang EE; Clancy TE; Russell S; Swanson RS; Ashley SW; Zinner MJ; Raut CP
Arch Surg; 2008 Nov; 143(11):1041-5; discussion 1046. PubMed ID: 19015460
[TBL] [Abstract][Full Text] [Related]
15. Safety and utility of liver biopsy after pediatric hematopoietic stem cell transplantation.
Oshrine B; Lehmann LE; Duncan CN
J Pediatr Hematol Oncol; 2011 Apr; 33(3):e92-7. PubMed ID: 21317809
[TBL] [Abstract][Full Text] [Related]
16. Allogeneic peripheral blood stem cell transplantation in patients with early-phase hematologic malignancy: a retrospective comparison of short-term outcome with bone marrow transplantation.
Lemoli RM; Bandini G; Leopardi G; Rosti G; Bonini A; Fortuna A; Rondelli D; Mangianti S; Motta MR; Rizzi S; Tassi C; Cavo M; Remiddi C; Curti A; Conte R; Tura S
Haematologica; 1998 Jan; 83(1):48-55. PubMed ID: 9542323
[TBL] [Abstract][Full Text] [Related]
17. Is the presence of 6 or fewer crypt apoptotic bodies sufficient for diagnosis of graft versus host disease? A decade of experience at a single institution.
Lin J; Fan R; Zhao Z; Cummings OW; Chen S
Am J Surg Pathol; 2013 Apr; 37(4):539-47. PubMed ID: 23211294
[TBL] [Abstract][Full Text] [Related]
18. Prognostic factors identifiable at the time of onset of acute graft-versus-host disease after allogeneic hematopoietic cell transplantation.
Lee KH; Choi SJ; Lee JH; Lee JS; Kim WK; Lee KB; Sohn SK; Kim JG; Kim DH; Seol M; Lee YS; Lee JH
Haematologica; 2005 Jul; 90(7):939-48. PubMed ID: 15996932
[TBL] [Abstract][Full Text] [Related]
19. [Effects and prognostic factors of HLA-matched sibling donor allogeneic hematopoietic stem cell transplantation for chronic myelogenous leukemia].
Tong XZ; Li J; Tan EX; Zhang GC; Wu XY; Peng AH; Zheng D; Zou WY; Hong WD; Luo SK
Zhonghua Zhong Liu Za Zhi; 2006 Jul; 28(7):545-8. PubMed ID: 17147125
[TBL] [Abstract][Full Text] [Related]
20. [Hematopoietic stem cell transplantation for patients with chronic myelogenous leukemia].
Liu QF; Sun J; Zhang Y; Liu XL; Xu D; Xu B; Feng R; Meng FY; Zhou SY
Ai Zheng; 2004 Apr; 23(4):426-9. PubMed ID: 15087032
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
